SALZANO, GIUSEPPINA
 Distribuzione geografica
Continente #
EU - Europa 1.065
NA - Nord America 916
AS - Asia 412
AF - Africa 8
SA - Sud America 4
OC - Oceania 1
Totale 2.406
Nazione #
US - Stati Uniti d'America 883
IT - Italia 705
SG - Singapore 194
CN - Cina 156
IE - Irlanda 75
FI - Finlandia 63
DE - Germania 61
NL - Olanda 40
UA - Ucraina 35
CA - Canada 30
IN - India 28
SE - Svezia 25
FR - Francia 22
VN - Vietnam 20
GB - Regno Unito 13
RU - Federazione Russa 9
CI - Costa d'Avorio 4
CL - Cile 4
EG - Egitto 4
ID - Indonesia 4
KR - Corea 4
TR - Turchia 4
MX - Messico 3
AT - Austria 2
BE - Belgio 2
CH - Svizzera 2
ES - Italia 2
PL - Polonia 2
AU - Australia 1
BA - Bosnia-Erzegovina 1
CZ - Repubblica Ceca 1
EE - Estonia 1
GR - Grecia 1
HK - Hong Kong 1
HU - Ungheria 1
LT - Lituania 1
NO - Norvegia 1
PK - Pakistan 1
Totale 2.406
Città #
Singapore 162
Chandler 131
Santa Clara 93
Millbury 73
Princeton 59
Nanjing 53
Naples 47
Ashburn 46
Beijing 28
Ottawa 28
Amsterdam 27
Boston 26
Napoli 26
Rome 26
Milan 21
Dong Ket 20
Pune 20
Hebei 17
Dallas 16
Nanchang 16
Wilmington 15
Falls Church 14
Preganziol 13
Des Moines 12
Florence 12
Dublin 11
Jacksonville 10
Jiaxing 10
Shenyang 10
Bologna 9
Salerno 9
Caserta 8
Ercolano 8
Norwalk 8
Cerro Maggiore 7
Mumbai 6
Padova 6
Alexandria 5
Ann Arbor 5
Palermo 5
San Francisco 5
Saratov 5
Sassari 5
Tianjin 5
Jakarta 4
Perugia 4
Valparaiso 4
Washington 4
Bacoli 3
Boardman 3
Cagliari 3
Campobasso 3
Canegrate 3
Cattolica 3
Changsha 3
Helsinki 3
Houston 3
Kunming 3
Medesano 3
New York 3
Nocera Inferiore 3
Ottaviano 3
Reggio Emilia 3
Scordia 3
Serra 3
Torre Annunziata 3
Trani 3
Acquanegra sul Chiese 2
Alcamo 2
Aragona 2
Arezzo 2
Aversa 2
Cambridge 2
Carolei 2
Cassola 2
Catania 2
Cesano Maderno 2
Conselice 2
Desio 2
Ferentino 2
Gela 2
Giussano 2
Indiana 2
Kronberg 2
Lausanne 2
London 2
Los Angeles 2
Modugno 2
Parma 2
Porcia 2
Redwood City 2
Rende 2
San Sebastian 2
Selargius 2
Shenzhen 2
Siena 2
Siliguri 2
Silvi 2
Sperone 2
Toronto 2
Totale 1.277
Nome #
Microsfere gastroresistenti per la somministrazione orale di bromelaina. 354
Microsfere di PLGA per il rilascio controllato di siRNA anti-TNF-alpha nel trattamento dell’artrite reumatoide. 181
Liposomi stealth contenenti acido zoledronico per il trattamento del dolore neuropatico 72
Nanoparticelle auto-assemblanti per la veicolazione di acido zoledronico nel trattamento di tumori nell’uomo. 64
Nanoparticelle autoassemblanti per il rilascio di bifosfonati nel trattamento di tumori. 62
Aggregati supramolecolari, formulati con monomeri anfifilici funzionalizzati con agenti chelanti e con peptidi e loro impiego per la somministrazione selettiva di farmaci e⁄o mezzi di contrasto 60
Lipid Nanovectors to Deliver RNA Oligonucleotides in Cancer 58
Nanoparticelle auto-assemblanti contenenti acido zoledronico: una nuova strategia per il trattamento del cancro. 55
Nanoparticelle auto-assemblanti per la veicolazione di acido zoledronico nel trattamento di tumori nell’uomo. 53
Bombesin labelled liposome as target -selective delivery system for doxorubicin 51
Acido zoledronico incapsulato nei liposomi: una nuova opportunità contro il cancro 50
Medical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acid 50
Transferrin-targeted nanoparticles containing zoledronic acid as a potential tool to inhibit glioblastoma growth 50
Zoledronic acid-encapsulating self-assembling nanoparticles and doxorubicin: A combinatorial approach to overcome simultaneously chemoresistance and immunoresistance in breast tumors 49
Bombesin peptide antagonist for target-selective delivery of liposomal doxorubicin on cancer cells 48
Multifunctional Polymeric Micelles Co-loaded with Anti-Survivin siRNA and Paclitaxel Overcome Drug Resistance in an Animal Model of Ovarian Cancer 44
NANOPARTICELLE AUTOASSEMBLANTI PER L???IMPIEGO DI BISFOSFONATI NEL TRATTAMENTO DEL GLIOBLASTOMA 43
Self-assembling nanoparticles encapsulating zoledronic acid revert multidrug resistance in cancer cells 43
Self-assembly nanoparticles for the delivery of bisphosphonates into tumors. 42
uso dell'acido zoledronico per la preparazione di formulazioni farmaceutiche per il trattamento del cancro della prostata e del mieloma multiplo. 40
Can stealth liposomes convert a bisphophonate in a anticancer agent? 40
Liposomi stealth contenenti bifosfonati: una nuova strategia contro il cancro. 38
Monogenic Diabetes accounts for 6.3% of cases referred to 15 Italian pediatric diabetes Centers during 2007-2012 36
Self-assembly lipid-based nanoparticles containing zoledronic acid: a new strategy for the treatment of cancer 35
Bisphosphonates and cancer: what opportunities from nanotechnology? 35
NEW CXCR4 INHIBITORS COUPLED WITH LIPOSOMES INHIBIT LUNG METASTASES DEVELOPMENT 35
CXCR4-antagonist Peptide R-liposomes for combined therapy against lung metastasis 32
PLGA microspheres encapsulating siRNA 31
Stealth liposomes encapsulating zoledronic acid: a new opportunity to treat neuropathic pain. 30
New self-assembly nanoparticles and stealth liposomes for the delivery of zoledronic acid: a comparative study 28
Scuola dottorale per la formazione avanzata in discipline tecnologico farmaceutiche 28
Nanotecnologie per l’impiego di bisfosfonati come farmaci antitumorali 28
PLGA MICROSPHERES FOR LONG TERM DELIVERY OF siRNA AGAINST TNFalfa IN THE TREATMENT OF RHEUMATOID ARTHRITIS. 27
New CXCR4 inhibitors coupled with liposomes inhibit lung metastases development. 27
Stealth liposomes and new self-assembly nanoparticles for the delivery of zoledronic acid: a comparative study. 26
Nanoparticelle autoassembanti per l???impiego di bisfosfonati nel trattamento di tumori. 25
Survey on etiological diagnosis of diabetes in 1244 Italian diabetic children and adolescents: Impact of access to genetic testing 25
Novel stealth self-assembled nanoparticles for the delivery of zoledronic acid in the treatment of solid tumors. 24
New self-assembling nanoparticles for bisphosphonate delivery in cancer. 24
Insights in the chemical components of liposomes responsible for P-glycoprotein inhibition. 24
Liposomes encapsulating zoledronic acid: a new opportunity against cancer. 23
Liposomes containing zoledronic acid: a new opportunity against cancer. 22
New self-assembly nanoparticles and stealth liposomes for the delivery of zoledronic acid: a comparative study. 22
Zoledronic acid delivered by self-assembly pegylated nanoparticles has antitumor efficacy against glioblastoma cell lines and xenografts. 21
PLGA microspheres for the delivery of siRNA against TNF-alpha in the treatment of rheumatoid arthritis 20
New self-assembling nanoparticles for bisphosphonate delivery in cancer. 19
Polymeric micelles containing reversibly phospholipid-modified anti-survivin siRNA: A promising strategy to overcome drug resistance in cancer. 19
Polymeric Micelles Co-Loaded with Survivin siRNA and Paclitaxel: A Strategy to Overcome the Multidrug Resistance in Tumor 19
Nanotechnologies to use bisphosphonates as potent anticancer agents: the effects of zoledronic acid encapsulated into liposomes 18
Stealth liposomes containing zoledronic acid for the treatment of neuropathic pain. 18
Self-assembling nanoparticles containing zoledronic acid: a new challenge for the treatment of brain tumors 18
SELF-ASSEMBLING NANOPARTICLES ENCAPSULATING ZOLEDRONIC ACID FOR THE TREATMENT OF BRAIN TUMORS 17
Tumour-Specific Uptake of Anti-Cancer Drugs: The Future is Here 17
Novel Self assembled nanoparticles for Tumor targeted delivery of Zoledronic acid. 16
Nanotechnologies for the delivery of zoledronic acid in tumors. 16
PLGA microspheres encapsulating siRNA anti-TNFalpha: Efficient RNAi-mediated treatment of arthritic joints. 15
Self-assembling nanoparticles for the release of bisphosphonates in the treatment of human cancers 14
null 12
null 10
null 10
NANOTECHNOLOGIES TO USE ZOLEDRONIC ACID AS A POTENT ANTITUMORAL AGENT 9
Nanotech Revolution for the Anti-Cancer Drug Delivery through Blood-Brain-Barrier. 9
null 8
Nanotechnologies: a strategy to overcome blood-brain barrier 7
null 5
Totale 2.451
Categoria #
all - tutte 9.841
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.841


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202079 0 0 0 0 0 1 4 1 5 19 37 12
2020/2021193 24 5 35 8 21 24 6 6 13 10 11 30
2021/2022382 14 2 11 9 8 21 6 17 74 4 65 151
2022/2023403 69 15 19 29 61 42 14 30 52 37 25 10
2023/2024433 22 36 82 25 27 61 17 37 6 20 62 38
2024/2025419 93 153 19 28 117 9 0 0 0 0 0 0
Totale 2.451